NIH Reporter #5R01CA283548-03

NCI Grant for Noninvasive High-Resolution Mapping of Liver Cancer Tumor Biology

This opportunity is a research grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), focused on advancing liver cancer diagnostics. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Purpose: - Grant for research on noninvasive, high-resolution mapping of hepatocellular carcinoma (HCC) tumor biology - Emphasis on using advanced imaging techniques, specifically Chemical Exchange Saturation Transfer (CEST) MRI - Research to be conducted in a pig HCC model - Goals: - Improve diagnosis, treatment stratification, and response monitoring for liver cancer patients - Develop imaging biomarkers predictive of malignancy - Products/Services Requested: - No specific products, part numbers, or quantities listed - No OEMs or vendors specified - Notable Requirements: - Focus on innovative imaging approaches for cancer detection - Research-oriented grant, not a procurement of commercial products - Estimated grant value: $628,443

Description

This NIH grant opportunity focuses on advanced imaging techniques, including CEST MRI, to noninvasively assess tumor biology in a pig HCC model. The project aims to improve diagnosis, treatment stratification, and response monitoring for liver cancer patients. It is sponsored by the National Cancer Institute (NCI), part of the NIH, and is currently active and open for applications. The estimated contract value is $628,443. The work is associated with cancer detection and diagnosis.

View original listing